Skip to ContentSkip to Navigation
Practical matters How to find us prof. dr. W. (Wim) Timens
University Medical Center Groningen

prof. dr. W. (Wim) Timens



Pulmonary pathology

Other positions

Board member Dutch Society for Pathology (Research)
Member Council Science and Innovation (Federation of Medical Specialists)
Member FMS Multidisciplinary Scientific commitee Covid19
Chair UMCG Cohort and Biobank Coördination Hub
Member Steering group project BIMS, (Biobank Information Management System), UMCG
Member Steering group project EDFR2.0 (EPD Data For Research), UMCG
Biobank coordinator regional Health-RI node UMCG
Chair Biobank Expert group (SD-CRO), UMCG
Member projectgroup Mutual Recognition Multicenter Biobanks
Board member GRIAC (Groningen Research Institute for Asthma and COPD)
Member Steering group ELSI (Ethical, Legal, Social Implications) Servicedesk
Member Health Sciences committee National Roadmap Large scale Scientific Infrastructure 2021
Member Sounding Board New Code of conduct Health Research
Vice chair Dutch Working group Lung Pathology (NWLP)
Member national Thymomapanel
Member LANS-panel (National Advisory committee Neoplasia of the Esophagus)
Member Editorial Board J. Pathology
Member Editorial Board J. COPD
National representative European Working group on Pulmonary Pathology
Co-founder and PI eQTL Lung consortium (collaboration UMC Groningen, UBC, Vancouver, CA, Laval University, Quebec, CA)
Between 2012-2021 (31-12-2021): from commercial partners he received honoraria ( all fees to UMCG) for expertise/ scientific advisory board/consultancy/ speakers fee: AbbVie, AstraZeneca, Bayer, BMS, Biotest Boehringer Ingelheim, Chiesi, Diaceutics; GSK, Lilly, MSD/Merck, Novartis, Pfizer, Roche/Ventana, Grants (investigator initiated) from Genentech, MSD/Merck, Roche/Ventana
Last modified:16 November 2022 4.59 p.m.

Contact information

Antonius Deusinglaan 1
9713 AV Groningen
The Netherlands

UMCG Dept. Pathology and Medical Biology